These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Bioinformatics and molecular modeling in glycobiology. Frank M; Schloissnig S Cell Mol Life Sci; 2010 Aug; 67(16):2749-72. PubMed ID: 20364395 [TBL] [Abstract][Full Text] [Related]
43. Some Trends in Chem(o)informatics. Warr WA Methods Mol Biol; 2011; 672():1-37. PubMed ID: 20838963 [TBL] [Abstract][Full Text] [Related]
44. Glycomics: a pathway to a class of new and improved therapeutics. Shriver Z; Raguram S; Sasisekharan R Nat Rev Drug Discov; 2004 Oct; 3(10):863-73. PubMed ID: 15459677 [TBL] [Abstract][Full Text] [Related]
45. JCGGDB: Japan Consortium for Glycobiology and Glycotechnology Database. Maeda M; Fujita N; Suzuki Y; Sawaki H; Shikanai T; Narimatsu H Methods Mol Biol; 2015; 1273():161-79. PubMed ID: 25753710 [TBL] [Abstract][Full Text] [Related]
46. De novo glycan structure search with the CID MS/MS spectra of native N-glycopeptides. Peltoniemi H; Joenväärä S; Renkonen R Glycobiology; 2009 Jul; 19(7):707-14. PubMed ID: 19270074 [TBL] [Abstract][Full Text] [Related]
47. Harnessing glycomics technologies: integrating structure with function for glycan characterization. Robinson LN; Artpradit C; Raman R; Shriver ZH; Ruchirawat M; Sasisekharan R Electrophoresis; 2012 Mar; 33(5):797-814. PubMed ID: 22522536 [TBL] [Abstract][Full Text] [Related]
48. Dealing with the Ambiguity of Glycan Substructure Search. Daponte V; Hayes C; Mariethoz J; Lisacek F Molecules; 2021 Dec; 27(1):. PubMed ID: 35011294 [TBL] [Abstract][Full Text] [Related]
49. Discovering new clinical markers in the field of glycomics. Telford JE; Doherty MA; Tharmalingam T; Rudd PM Biochem Soc Trans; 2011 Jan; 39(1):327-30. PubMed ID: 21265797 [TBL] [Abstract][Full Text] [Related]
50. Implementation of GlycanBuilder to draw a wide variety of ambiguous glycans. Tsuchiya S; Aoki NP; Shinmachi D; Matsubara M; Yamada I; Aoki-Kinoshita KF; Narimatsu H Carbohydr Res; 2017 Jun; 445():104-116. PubMed ID: 28525772 [TBL] [Abstract][Full Text] [Related]
51. The role of the informatics framework in early lead discovery. Fay N Drug Discov Today; 2006 Dec; 11(23-24):1075-84. PubMed ID: 17129826 [TBL] [Abstract][Full Text] [Related]
53. Transforming the work of early-stage drug discovery through bioprocess informatics. Holzman TF; Hebert EJ Drug Discov Today; 2005 Jan; 10(1):61-7. PubMed ID: 15676300 [TBL] [Abstract][Full Text] [Related]
56. Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognition. Seppälä U; Selby D; Monsalve R; King TP; Ebner C; Roepstorff P; Bohle B Mol Immunol; 2009 Jun; 46(10):2014-21. PubMed ID: 19375166 [TBL] [Abstract][Full Text] [Related]
57. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. Ceroni A; Maass K; Geyer H; Geyer R; Dell A; Haslam SM J Proteome Res; 2008 Apr; 7(4):1650-9. PubMed ID: 18311910 [TBL] [Abstract][Full Text] [Related]
58. N-glycan profiling in the study of human aging. Vanhooren V; Laroy W; Libert C; Chen C Biogerontology; 2008 Oct; 9(5):351-6. PubMed ID: 18431686 [TBL] [Abstract][Full Text] [Related]
59. GlycoPattern: a web platform for glycan array mining. Agravat SB; Saltz JH; Cummings RD; Smith DF Bioinformatics; 2014 Dec; 30(23):3417-8. PubMed ID: 25143288 [TBL] [Abstract][Full Text] [Related]